Results 221 to 230 of about 19,152,238 (244)

Nuclear-Cytoplasmic Axis in Cancer: From Protein Mislocalization to Anticancer Drug Resistance. [PDF]

Oncol Res
Zhu X, He M, Wang L, Su R, Zhong L, Guo T, Wang H, Zou D.   +7 more
europepmc   +1 more source

Structural and mechanistic basis of mTORC2 activation of protein kinase AKT/PKB. [PDF]

Biochem J
Chu N, Le N, Nebie O, Yang S.
europepmc   +1 more source

Y-box binding protein-1 at the crossroads of DNA damage response and tumor immune evasion. [PDF]

JNCI Cancer Spectr
Toulany M, Sodji QH.
europepmc   +1 more source

Nummular Dermatitis Following an Insect Bite in a Patient With Activated Phosphoinositide-3-Kinase Delta Syndrome (APDS): A Case Report and Literature Review. [PDF]

Cureus
Hernandez-Carrasco A, Fuentes-Calvo I, Arechavala-Lopez SF, Hernandez-Carrasco V, Soriano-Hernandez YL, García-Galicia A, Contreras-Sánchez ZA, Carrasco-Trinidad G.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients

Cancer Treatment Reviews, 2017
Filip Janku
exaly  

Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents

Current Opinion in Pharmacology, 2003
Stephen G Ward, Peter Finan
exaly  

Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors

Bioorganic and Medicinal Chemistry Letters, 2012
Yusuke Oka, Mayumi Endo, Yoshinori Sekiguchi   +2 more
exaly  

The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1)

European Journal of Medicinal Chemistry, 2010
Allan Wissner, Andrea Olland, Yongbo Hu
exaly  

Regioselective synthesis of 5- and 6-methoxybenzimidazole-1,3,5-triazines as inhibitors of phosphoinositide 3-kinase

Bioorganic and Medicinal Chemistry Letters, 2013
Jo-Anne Pinson, Ian G. Jennings, Philip E. Thompson   +2 more
exaly